Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label, multicenter study to assess the efficacy of switching to a combination tablet ezetimibe/simvastatin 10mg/40mg, compared to doubling the dose of statin in patients hospitalized with a coronary event

X
Trial Profile

An open-label, multicenter study to assess the efficacy of switching to a combination tablet ezetimibe/simvastatin 10mg/40mg, compared to doubling the dose of statin in patients hospitalized with a coronary event

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ezetimibe/simvastatin (Primary)
  • Indications Hypercholesterolaemia; Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms INFORCE
  • Sponsors Merck & Co; Organon
  • Most Recent Events

    • 13 Oct 2012 Planned number of patients changed from 450 to 490.
    • 07 Jun 2010 Data from this trial was used in an economic analysis published in Value in Health.
    • 24 Oct 2009 Data from the trial was used in an economic analysis presented at the 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top